I now have enough information from Park's Textbook to write a comprehensive 10-mark answer. Let me compile everything into a well-structured response.
Malaria: Diagnosis, Epidemiological Determinants, Complications & Prevention
(Park's Textbook of Preventive and Social Medicine)
a) Diagnosis
Diagnosis of malaria depends on demonstration of the parasite in blood. Suspicion is aroused by epidemiological and clinical evidence (history of residence/travel in endemic area, fever with periodicity).
1. Microscopy (Gold Standard)
- Both thick film and thin film are prepared on a single glass slide.
- Thick film: More sensitive - detects scanty parasites ~20x faster; used to search for parasites.
- Thin film: Better species identification - parasites seen more clearly.
- Stain used: Leishman stain or Giemsa stain.
- Limitation: Requires trained microscopist; time-consuming.
2. Clinical/Presumptive Diagnosis
- Based on symptoms: fever with intermittent periodicity (48 hrs for P. vivax/P. falciparum; 72 hrs for P. malariae), splenomegaly, anaemia.
- Three stages of febrile paroxysm: Cold stage → Hot stage → Sweating stage.
- As per revised drug policy 2013, presumptive treatment alone is no longer acceptable; parasitological confirmation is mandatory.
3. Rapid Diagnostic Tests (RDTs)
- Based on detection of circulating parasite antigens using a simple dipstick format.
- Some kits detect P. falciparum only; others detect multiple species (but are expensive and temperature-sensitive).
- Useful in field settings where microscopy is unavailable.
- Important: Always read user manual to avoid false-negative results.
4. Other methods: PCR (research settings), serology (epidemiological surveys, not for clinical diagnosis).
b) Epidemiological Determinants
Malaria epidemiology is governed by the Agent-Host-Environment triad:
Agent Factors
- Causative organism: Plasmodium species - P. falciparum, P. vivax, P. ovale, P. malariae
- P. falciparum is most dangerous and prone to complications
- Gametocytes (infective stage to mosquito): appear 4-5 days post-asexual parasites in vivax; 10-12 days in falciparum
- Drug resistance: P. falciparum is resistant to chloroquine and sulfadoxine-pyrimethamine in most endemic areas → necessitating Artemisinin-based Combination Therapy (ACT)
Host Factors
- Age: Affects all ages; newborns have relative resistance due to fetal haemoglobin (suppresses P. falciparum)
- Sex: Males more exposed due to outdoor life
- Race/Genetics:
- Sickle-cell trait (AS haemoglobin) - protective against P. falciparum
- "Duffy-negative" individuals - resistant to P. vivax
- Pregnancy: Increases risk; may cause intrauterine death, premature labour, abortion; primigravidae most at risk
- Immunity: Repeated infections build partial immunity
- Socio-economic status: Malaria has declined in developed countries with economic development
- Housing: Ill-ventilated, ill-lit houses favour indoor resting of mosquitoes
Environmental/Vector Factors
- Vector: Female Anopheles mosquito (over 60 species implicated)
- Breeding sites: Stagnant, clean water - pools, ponds, rice fields, construction sites
- Temperature: Optimal 20-30°C; sporogony (parasite development in mosquito) ceases below 16°C
- Rainfall and humidity: Promotes mosquito breeding
- Season: Transmission peaks post-monsoon in India (August-November)
- Geography: Forest, forest-fringe, tribal areas have highest burden in India; northeastern states, Chhattisgarh, Jharkhand, Odisha, MP, Maharashtra account for ~91% of cases and 99% of deaths in India
c) Complications
P. falciparum Complications (Severe/Complicated Malaria)
P. falciparum causes cytoadherence of infected RBCs to vascular endothelium (sequestration), leading to organ damage:
| Complication | Features |
|---|
| Cerebral malaria | Coma/impaired consciousness, seizures, high mortality (15-20%); mainly children and non-immune adults |
| Acute renal failure | Tubular necrosis; oliguria/anuria; "malarial nephropathy" |
| Blackwater fever | Massive intravascular haemolysis → haemoglobinuria → dark/black urine; renal failure |
| Severe anaemia | Due to haemolysis + dyserythropoiesis |
| Pulmonary oedema / ARDS | Non-cardiogenic; high mortality |
| Hypoglycaemia | From parasites consuming glucose + quinine-induced insulin release |
| Liver damage | Malarial hepatitis, jaundice |
| Circulatory collapse | "Algid malaria" - septicaemic shock |
| Abnormal bleeding / DIC | Thrombocytopaenia |
| Hyperpyrexia | Temperature >41°C |
| Gastrointestinal | Vomiting, diarrhoea, dehydration |
P. vivax / P. ovale / P. malariae Complications
- Anaemia
- Splenomegaly (can lead to splenic rupture)
- Hepatomegaly
- Herpes labialis (febrile herpes)
- P. malariae - nephrotic syndrome (quartan malarial nephropathy), chronic low-grade parasitaemia lasting 40+ years
d) Prevention
Prevention is multi-pronged under India's National Vector Borne Disease Control Programme (NVBDCP):
1. Personal Prophylaxis (Individual Protection)
- Chemoprophylaxis: Chloroquine (where sensitive) for travelers/high-risk groups; Doxycycline or Mefloquine for resistant areas
- Insect repellents: DEET-based repellents on exposed skin
- Protective clothing: Long sleeves, long pants, especially at dusk/dawn
- Bed nets: Insecticide-Treated Bed Nets (ITNs) / Long Lasting Insecticidal Nets (LLINs)
- Window/door screening
2. Vector Control
- Indoor Residual Spraying (IRS): DDT, Malathion, synthetic pyrethroids sprayed on indoor walls - kills mosquitoes resting on treated surfaces
- Larval control (Anti-larval measures):
- Source reduction: eliminating breeding sites (draining stagnant water, filling depressions)
- Larviciding: Paris green, petroleum oils, temephos (Abate)
- Biological control: Gambusia fish (larva-eating fish), Bacillus thuringiensis israelensis (Bti)
- Environmental management: Drainage of swamps, proper irrigation management, solid waste disposal
3. Case Detection and Treatment (Surveillance)
- Passive case detection: Fever cases reporting to health facilities tested and treated promptly
- Active case detection: Health workers visit households in high-risk areas
- Radical treatment: Complete treatment (primaquine for P. vivax to kill hypnozoites and prevent relapse)
- Sentinel surveillance
4. Health Education and Community Participation
- Awareness about mosquito breeding prevention
- Proper use of bed nets
- Seeking early treatment for fever
5. Epidemic Preparedness
- Stock-piling of drugs, insecticides, RDTs
- Rapid response teams
6. Malaria Vaccines
- RTS,S/AS01 (Mosquirix): First licensed malaria vaccine (WHO recommended 2021); targets P. falciparum; partial efficacy (~30-50%)
Summary Table
| Aspect | Key Points |
|---|
| Diagnosis | Thick/thin smear (gold standard), RDT, PCR |
| Epidemiology | Anopheles vector, Plasmodium agent, host immunity/genetics, environment |
| Complications | Cerebral malaria, ARF, blackwater fever, ARDS (P. falciparum); splenomegaly, nephrotic syndrome (P. malariae) |
| Prevention | IRS, ITNs/LLINs, larval control, chemoprophylaxis, early diagnosis & treatment |
(Source: Park's Textbook of Preventive and Social Medicine, 26th Ed.)